Capital International Investors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-124,831
Closed -$2.44M – 481
2021
Q3
$2.44M Sell
124,831
-798,264
-86% -$30.4M ﹤0.01% 442
2021
Q2
$41.4M Buy
923,095
+262,847
+40% +$12.2M 0.01% 375
2021
Q1
$33.2M Buy
660,248
+507,940
+333% +$34.6M 0.01% 371
2020
Q4
$13.6M Sell
152,308
-96,404
-39% -$8.11M ﹤0.01% 400
2020
Q3
$19M Buy
+248,712
New +$15.8M 0.01% 375

Other funds holding CELL

Capital International Investors's CELL Position: Q4 2021 in Review

Capital International Investors sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2021, closing a stake of 124,831 shares — an estimated $2.44M sold.

Capital International Investors first reported a position in CELL in Q3 2020 and held it in 5 quarters. The position peaked at $41.4M in Q2 2021. 132 funds tracked by Wall St. Rank hold CELL as of Q4 2021.

  • Capital International Investors reported no remaining PhenomeX Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Capital International Investors sold 124,831 PhenomeX Inc. Common Stock shares in Q4 2021, an estimated $2.44M.
  • Capital International Investors first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Capital International Investors's PhenomeX Inc. Common Stock position peaked at $41.4M in Q2 2021.
  • 132 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2021.

Based on Capital International Investors's 13F filing for Q4 2021, filed 14 Feb 2022.